Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction (2013)
- Autores:
- Autores USP: LACCHINI, RICCARDO - FMRP ; JORDAO JUNIOR, ALCEU AFONSO - FMRP ; TUCCI JUNIOR, SILVIO - FMRP ; MARTINS, ANTONIO CARLOS PEREIRA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00210-013-0882-z
- Assuntos: DISFUNÇÃO ERÉTIL; ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO
- Idioma: Inglês
- Imprenta:
- Local: Heidelberg
- Data de publicação: 2013
- Fonte:
- Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology
- ISSN: 0028-1298
- Volume/Número/Paginação/Ano: v. 386, n. 9, p. 805-811, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MUNIZ, Jaqueline J. et al. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 386, n. 9, p. 805-811, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00210-013-0882-z. Acesso em: 19 set. 2024. -
APA
Muniz, J. J., Lacchini, R., Sertório, J. T. C., Jordão Júnior, A. A., Nobre, Y. T. D. A., Tucci Júnior, S., et al. (2013). Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction. Naunyn-Schmiedeberg's Archives of Pharmacology, 386( 9), 805-811. doi:10.1007/s00210-013-0882-z -
NLM
Muniz JJ, Lacchini R, Sertório JTC, Jordão Júnior AA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 9): 805-811.[citado 2024 set. 19 ] Available from: https://doi.org/10.1007/s00210-013-0882-z -
Vancouver
Muniz JJ, Lacchini R, Sertório JTC, Jordão Júnior AA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 9): 805-811.[citado 2024 set. 19 ] Available from: https://doi.org/10.1007/s00210-013-0882-z - Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
- Comparative assessment of circulating matrix metalloproteinases and their endogenous inhibitors in erectile dysfunction
- Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil
- Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
Informações sobre o DOI: 10.1007/s00210-013-0882-z (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
